𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maple syrup urine disease-therapeutic use of insulin in catabolic states

✍ Scribed by U. Wendel; U. Langenbeck; Ingrid Lombeck; H. J. Bremer

Publisher
Springer
Year
1982
Tongue
English
Weight
329 KB
Volume
139
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mutational spectrum of maple syrup urine
Mutational spectrum of maple syrup urine disease in Spain
✍ Pilar RodrΓ­guez-Pombo; Rosa Navarrete; BegoΓ±a Merinero; Paulino GΓ³mez-Puertas; M πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 496 KB

Mutations in any of the three different genes BCKDHA, BCKDHB, and DBT encoding for the E1alpha, E1beta, and E2 catalytic components of the branched-chain alpha-ketoacid dehydrogenase (BCKD) complex can cause maple syrup urine disease (MSUD). The disease presents heterogeneous clinical and molecular

Exchange transfusion in acute episodes o
Exchange transfusion in acute episodes of maple syrup urine disease
✍ U. Wendel; U. Langenbeck; I. Lombeck; H. J. Bremer πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 428 KB

Two neonates with maple syrup urine disease were treated by exchange transfusion. Within 15 h blood leucine and K/CA concentrations were lowered from 2.6raM to 1.1raM using 570 to 620ml blood per kg body weight. The other branched-chain amino acid/keto acid pairs fell to normal. During exchange tran